Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Can Urogen Pharma Urgn Stock Recover Now Urgn Q4 Earnings Misses Estimates By 0.03 20260410 1 Bby Stock Analysis Best Buy Co. Inc. Posts Modest Gain Holds 64.5 Price Point 20260403 1 Is Ouster Oust Stock Good For Passive Investors Price At 19.28 Down 1.08 20260406 Is Equillium Eq Stock Good For Passive Investors Price At 2.01 Up 2.03 20260406 Is Royce Rvt Stock Worth Holding Price At 16.72 Down 1.07 20260406 Coffee JVA shares climb 4 as 226 revenue growth offsets earnings miss surprising investors Why Eaton ETV could deliver where others fall short Bearish Sentiment 20260507 ARQQ Arqit Quantum Inc Ordinary Shares reports 809 percent year over year Q4 2025 revenue growth shares dip 283 percent BLFY Blue Foundry Bancorp Q3 2025 earnings narrowly miss consensus estimates amid rising operational headwinds LandBridge LB Stock Future Performance Expectations Ticks Higher 20260423 MAR Marriott International posts 43 percent Q4 revenue growth as shares rise slightly despite a narrow EPS miss What Republic RDAGW disclosed about liquidity position RDAGW Republic Warrants Flat as Deal Progress Lags How is the market affecting BNY Mellon BKK stock today P3 Health PIII Stock Is It Testing Levels 077 20260420 The quiet positioning of Kopin Corporation KOPN nobody discusses Grinds Lower 20260508 SA Seabridge shares dip 03 in todays trading after reporting negative Q1 2024 earnings per share BLTE Belite Bio misses Q4 earnings estimates by 256 percent posts zero revenue shares dip slightly SBXE SilverBox management lays out targeted growth priorities for upcoming fiscal year in quarterly earnings release Deere Co DE PostRally Valuation Assessment Is Upside Still On The Table Indias Adani Group Agrees to 18 Million Settlement in US Civil Fraud Case Indias Design Ambition Shifts to Commercialisation as Leaders Eye Global Innovation Leadership Precious Metals Extend Decline as Market Weighs Correction vs Buying Opportunity BNY Muni Fund DSM Declines 098 Amid Market Weakness 20260515 ADSTEC ADSE Stock Today Rallies 096 Resistance at 1218 20260519 Trump Administration Drops Criminal Charges Against Adani Following 10 Billion US Investment Pledge Wintrust WTFC Stock Consolidating at 14630 Next Move Ahead 20260519 RussiaChina Strategic Triangle Putins Beijing Visit Tests Energy Ties Tonix TNXP Stock Analysis 576 Gain What to Watch 20260520 Silicon Laboratories SLAB Steady at 21689 Awaiting Next Catalyst 20260520 WLFC Q1 2026 Earnings Earnings Surge on Strong Engine Leasing Demand Stock Climbs 195 EU Considers Tariffs and Supply Chain Shifts as Trade Tensions With China Escalate Retail Investors Gain Direct Access to SpaceX IPO via Robinhood Fidelity and Charles Schwab Microsoft Names Jenny LayFlurrie to Lead Trusted Technology Amid AI Speed vs Responsibility Debate SpaceX IPO May Raise 75 Billion But NVIDIA Could Be the LongTerm Winner Mercury Fintech Hits 52 Billion Valuation After Funding Round Surging 49 in 14 Months YELP Q1 2026 Earnings EPS Beats Estimates Stock Rises CYRX Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Operational Pressures Citizens Community Bancorp CZWI Q1 2026 Earnings EPS Beats Estimates by 621 as Company Reports Solid Net Income AEMD Q1 2026 Earnings Slightly Better Than Expected Loss Amid No Revenue GTES Q1 2026 Earnings EPS Beat Drives Positive Market Reaction KalVista Pharmaceuticals KALV Holds Steady Near Resistance as Investors Eye Key Catalysts Basel Medical Group BMGL Slides 277 as Selling Pressure Intensifies Nears Critical Support Nuveen California AMTFree Municipal Income Fund NKX Climbs 087 Approaches Key Resistance at 1320 Oil Prices Surge 4 After Trump Rejects Irans Ceasefire Response HR Block HRB Q1 2026 Beat Revenue NA EPS Exceeds by Significant Avista AVA Reports Strong Q1 2026 Revenue NA EPS Beats Arm ARM Reports Strong Q1 2026 Revenue NA EPS Beats Cramer Allowing Nvidia to Sell AI Chips in China Could Benefit US Tech Leadership Biotech Sector Outlook Navigating Innovation and Market Uncertainty ANI Pharma ANIP Q1 2026 Beat Revenue NA EPS Exceeds by Significant